Susquehanna International Group, LLP Nano Vibronix, Inc. Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.25 - $9.02 $18,728 - $675,724	-74,914 Reduced 82.11%	16,325 $4,000
Q3 2022 Nov 14, 2022	BUY	$0.43 - $10.32 $39,232 - $941,586	91,239 New	91,239 $42,000
Q1 2022 May 16, 2022	SELL	$0.7 - $1.16 $14,868 - $24,639	-21,241 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.0 - $2.0 $21,241 - $42,482	21,241 New	21,241 $22,000
Q4 2020 Feb 16, 2021	SELL	$0.56 - $1.13 $6,700 - $13,521	-11,966 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.59 - $2.24 $7,059 - $26,803	11,966 New	11,966 $8,000
Q4 2018 Feb 14, 2019	SELL	$3.05 - $4.64 $47,232 - $71,855	-15,486 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$4.17 - $4.89 $64,576 - $75,726	15,486 New	15,486 $71,000

Ticker NAOV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,997,800
Market Cap $16.2M
Description
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary ca...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.